IGF1R and T-cell non-Hodgkin lymphoma: In further support of an important role of IGF-IR in the pathogenesis of NPM-ALK+ T cell lymphoma, our current data show that acquired resistance to ALK inhibition is associated with a remarkable increase in the phosphorylation of IGF-IR.